文献速递生殖医学

体外受精与胚胎移植后使用高糖基化hCG与Elecsys HCG+β检测法早期检测妊娠的比较

Early detection of pregnancy after IVF and embryo transfer with hyperglycosylated HCG versus Elecsys HCG+β assay.
PubMed 文献 · Reprod Biomed Online · 2021-10-23

本研究纳入155名接受体外受精与胚胎移植的女性,在移植后第4、7、11天检测血清高糖基化hCG与HCG+β浓度,评估两者预测妊娠的性能。结果显示第4天两种标志物的AUC无显著差异,诊断性能从第4天到第11天改善,未证明高糖基化hCG优于HCG+β。

要点

  • 移植后第4天高糖基化hCG与HCG+β的AUC分别为0.88与0.90,无显著差异。
  • 第7天和第11天的预测性能较第4天更高,两种标志物间无显著差异。
  • 第4天临界值下,高糖基化hCG与HCG+β的阴性预测值分别为83.8%与82.8%,阳性预测值分别为89.0%与84.9%。

核心结论

  • 移植后第5天囊胚的早期妊娠预测性能在高糖基化hCG与HCG+β之间无显著差异;未证明高糖基化hCG优于HCG+β。

研究设计与样本

  • 研究纳入155名年龄18-45岁、接受第一次或第二次新鲜或冷冻体外受精胚胎移植周期的女性。
  • 在胚胎移植后第4天(+1)、第7天(+1)和第11天(+2)采集血样。
  • 第11天通过HCG测定评估生化妊娠;第21天(+4/-3)通过超声评估临床妊娠。
  • 检测血清高糖基化hCG(免疫化学发光法)和HCG+β(Elecsys® HCG+β检测法)浓度,评估预测妊娠的性能并选择临界值。

主要发现

  • 第4天高糖基化hCG的AUC为0.88(95%CI 0.83至0.94),HCG+β的AUC为0.90(95%CI 0.84至0.95),两者无显著差异。
  • 第7天和第11天的预测性能与第4天相比AUC估计值更高,两种标志物间无显著差异。
  • 采用第4天根据约登指数得出的临界值(高糖基化hCG 100 pg/ml;HCG+β 1.30 mIU/ml),第21天排除妊娠的阴性预测值高糖基化hCG为83.8%、HCG+β为82.8%,确认妊娠的阳性预测值高糖基化hCG为89.0%、HCG+β为84.9%。
  • 诊断性能从第4天到第11天改善。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Is measurement of hyperglycosylated HCG (hHCG) superior to beta-HCG (HCG+β) for early pregnancy detection after IVF and embryo transfer? DESIGN: Blood samples were collected on day 4 (+1), 7 (+1) and 11 (+2) after embryo transfer from women aged 18-45 years undergoing first or second fresh or frozen IVF embryo transfer cycles. Biochemical pregnancy was assessed on-site by HCG determination on day 11; clinical pregnancy was assessed by ultrasound on day 21 (+4/-3). Serum hHCG (immunochemiluminometric assay) and HCG+β (Elecsys® HCG+β assay) concentrations were measured. Performance of hHCG and HCG+β for predicting pregnancy was evaluated and cut-offs selected. RESULTS: In total, 155 women were enrolled and underwent IVF and embryo transfer. Area under the curve (AUC) (95% CI) on day 4 was not significantly different for hHCG (AUC 0.88; 95% CI 0.83 to 0.94) and HCG+β (AUC 0.90; 95% CI 0.84 to 0.95), as was predictive performance on day 7 and 11, with higher AUC estimates compared with day 4. Applying cut-offs derived according to Youden's index on day 4 (hHCG, 100 pg/ml; HCG+β, 1.30 mIU/ml), both biomarkers demonstrated high negative predictive values for ruling out pregnancy (hHCG, 83.8%; HCG+β, 82.8%) and high positive predictive values for ruling in pregnancy (hHCG, 89.0%; HCG+β, 84.9%) on day 21. Diagnostic performance improved from day 4 to day 11. CONCLUSIONS: Predictive performance for early pregnancy post-IVF embryo transfer of day-5 blastocysts was not significantly different for hHCG and HCG+β; hHCG superiority over HCG+β was not shown.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Bosch E, Hund M, van der Does R, et al. Early detection of pregnancy after IVF and embryo transfer with hyperglycosylated HCG versus Elecsys HCG+β assay. Reprod Biomed Online. 2021. PMID: 34924288. doi:10.1016/j.rbmo.2021.10.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。